Related Experiment Videos
Systemic Lupus Erythematosus and Pregnancy.
Aisha Lateef1, Michelle Petri2
1Division of Rheumatology, University Medicine Cluster, National University Hospital, National University Health System, 1E, Kent Ridge Road, Singapore 119074.
Rheumatic Diseases Clinics of North America
|April 10, 2017
Summary
Systemic lupus erythematosus (SLE) in pregnancy poses high risks for mothers and babies, increasing mortality and morbidity. Careful monitoring and multidisciplinary care are crucial for managing this complex autoimmune condition during pregnancy.
Area of Science:
- Immunology
- Obstetrics
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) disproportionately affects women, presenting unique challenges during pregnancy.
- Pregnancy in SLE patients is associated with elevated maternal and fetal risks, despite medical advancements.
Purpose of the Study:
- To review the risks and management strategies for Systemic Lupus Erythematosus (SLE) during pregnancy.
- To highlight the importance of a multidisciplinary approach for optimizing outcomes in pregnant SLE patients.
Main Methods:
- Literature review focusing on maternal and fetal complications in SLE pregnancies.
- Analysis of current treatment limitations and risk-benefit considerations for SLE management during gestation.
Main Results:
- Pregnant women with SLE face increased risks of disease flares, preeclampsia, and other obstetric complications.
- Fetal complications include higher rates of preterm birth, intrauterine growth restriction, and neonatal lupus.
Conclusions:
- Managing SLE during pregnancy requires careful consideration of limited treatment options and potential fetal risks.
- A coordinated, multidisciplinary team approach with close patient monitoring is essential for improving maternal and fetal outcomes in SLE pregnancies.